Lixte Biotechnology Holdings Inc. (LIXTW)
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
Cassava Sciences Inc. (SAVA)
Cassava Announces Agreement to Settle Securities Class Action Litigation
Reviva Pharmaceuticals Holdings Inc. (RVPHW)
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
Cassava Sciences Inc. (SAVAW)
Cassava Announces Agreement to Settle Securities Class Action Litigation
Trinity Biotech plc (TRIB)
Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests
Zai Lab Limited (ZLAB)
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia
Bausch&Lomb Corp (BLCO)
Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals to Participate in Upcoming January 2026 Events
Invivyd Inc (IVVD)
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID